 Basilea Pharmaceutica Ltd SIX: BSLN, a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the ... Read Full Story at source may require registration The post Continued strong Cresemba isavuconazole sales by Astellas in the U.S. trigger CHF 20 million sales milestone payment to Basilea appeared first on ForexTV... 